(312) 212-3470 info@goldanchormarker.com

About Naslund Medical

placeholder

Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with a subsidiary in the U.S. and contracted distributors on a global level.

Ingemar Näslund founder of Naslund Medical Owner and inventor
Ingemar Naslund, M.D, Ph.D. Associate professor in Oncology
ingemar.naslund@goldanchormarker.com

Background

The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Theraphy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.

Contact details

Naslund Medical AB
Vassvagen 21
14139 Huddinge, Sweden
Phone: +46 706 105 411
Fax: +46 850 900 381

Naslund Medical Inc.
150 N Michigan Ave, Suite 1950
Chicago, IL 60601, USA
Phone: (312) 212 3470
Fax: (312) 277 6688

Email: info@goldanchormarker.com

Quality Management System

Naslund Medical AB is certified to SS-EN ISO 13485:2012 and according to the Directive 93/42/EEC on Medical Devices, Annex II, Full Quality Assurance System.

Exhibitions and Events

We look forward to meet with you at an upcoming event. Or maybe we already met some of your colleagues at these recent meetings?

Events 2018 onwards

ASTRO Oct 21-23 San Antonio, Texas Link
ISIT2018 Nov 10-11 Saga, Japan Link
SABR Consortium Nov 29-30 Bristol, United Kingdom Link
RSS, The Radiosurgery Society March 21-23 2019 San Diego, California Link

Recent meetings

PTCOG 57 May 23-25, 2018 Cincinnati, Ohio Link
AUA, American Urological Association May 18-21, 2018 San Francisco, California Link
ARS, American Radium Society, 100th Annual meeting May 5-8, 2018 Orlando, Florida Link
ESTRO 37 April 20-24, 2018 Barcelona, Spain Link
NAPT, The National Proton Conference March 25-28, 2018 Scottsdale, Arizona Link
2017 RSS Annual Scientific Meeting (the Radiosurgery Society) November 2-4, 2017 Las Vegas, NV, USA Link
PTCOG-NA October 23-25, 2017 Chicago, IL, USA Link
ASTRO September 24-26, 2017 San Diego, CA, USA Link
UKRCO June 12-14, 2017 Manchester, United Kingdom Link
PTCOG 56 May 11-13, 2017 Yokohama, Kanagawa, Japan Link
ARS 99th Annual Meeting (American Radium Society) May 6-9, 2017 Colorado Springs, CO, USA Link
ESTRO 36 May 5-8, 2017 Vienna, Austria Link
Sjuksköterskor i Cancervård April 27-28, 2017 Stockholm, Sweden Link
Finska Strålbehandlingsdagarna (Finnish Radiotherapy Days) April 6-7, 2017 Helsinki, Finland Link
Proton Therapy Congress March 29-30, 2017 Amsterdam, the Netherlands Link
NCoBC2017: The 27th Annual Interdisciplinary Breast Center Conference March 11-13, 2017 Las Vegas, NV, USA Link
NACP symposium (Nordic Association for Clinical Physics) February 6-8, 2017 Oslo, Norway Link
ASTRO’s 58th Annual Meeting September 25-27, 2016 Boston, MA, USA. Booth #702 Link
The SRS/SBRT Scientific Meeting 2016 June 16-18, 2016 Orlando, FL, USA. Booth Link
ESTRO 35 April 29-May 3, 2016 Turin, Italy. Booth #1800 Link
2016 Genitourinary Cancers Symposium January 7-9, 2016 San Francisco, CA, USA Link
JASTRO’s 28th Annual Meeting November 19-21, 2015 Beisia Culture Hall, Maebashi, Japan Link
ASTRO’s 57th Annual Meeting October 18-21, 2015 San Antonio, TX, USA. Booth #702 Link

Partnership with academia & healthcare

Swedish Testbed for Innovative Radiotherapy

Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >

gentletherapy

Gentle Radiotherapy

Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.

Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment. Learn more >

gentle-radiotherapy

mail sign

Subscribe to our newsletter

Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.

By clicking Subscribe, you agree to that you have read our Privacy Policy including Cookies.